EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
China approves first drug for mild to moderate Alzheimer’s in 17 years
hinese Pharmaceutical Company Green Valley announces their drug Oligomannate (GV-971) has been granted conditional approval for the treatment of "mild to moderate Alzheimer's disease".
Thinking more deeply about dementia friendly initiatives
This piece questioning how we see and understand dementia friendly communities, their role and how they may evolve was contributed to the World Alzheimer Report 2019 by Glenn Rees, former Chair of ADI, and Dr Linda Barclay, a Senior Lecturer in Philosophy at Monash University who specialises in disability and justice.
Biogen and Eisai announce plans to file for market approval of Alzheimer’s drug
Biogen and Eisai have announced they will file for market approval for an investigational treatment for early Alzheimer’s disease.
Dementia given high priority at G20 Health Ministers Meeting
Ahead of the G20 Health Ministers Meeting in Okayama, ADI’s Chief Executive Paola Barbarino and Noriyo Washizu of Alzheimer's Association Japan (AAJ) continue to work on progress made earlier in the year at the Osaka Summit.
ADI interviewed by major Japanese newspaper ahead of G20 meeting
Ahead of the G20 Health Ministers Meeting in Okayama, ADI Chief Executive Paola was interviewed by one of Japan's largest newspaper.
Spanish government launches national plan to tackle dementia
The Spanish Ministry of Health, Consumption and Social Welfare has announced that they have adopted a national dementia plan.
Alzheimers New Zealand – The Dementia Declaration
New Zealand's Dementia Declaration is the result of people affected by dementia getting together and identifying what they need to live well.
World’s largest dementia study reveals two thirds of people still incorrectly think dementia is a normal part of ageing, rather than a medical condition
Results from the world’s largest survey reveals that stigma around dementia is preventing people from seeking the information, advice, support and medical help.